Tyrosine kinase inhibition: an approach to drug development.
Keyse
S M
SM
ICRF Molecular Pharmacology Unit, Dundee, UK.
D015195:Drug Design; D006801:Humans; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
D011505:Protein-Tyrosine Kinases